To speed development of COVID-19 treatments, Japan may utilize “compassionate use” regulatory exemption
A 2016 law that allows the administration of unapproved drugs in Japan when they may aid patients suffering from an otherwise fatal disease may be utilized to test COVID-19 treatments in the country. Known as the “compassionate use” system, the law permits... Read More